SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-21-068370
Filing Date
2021-03-04
Accepted
2021-03-04 06:06:18
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 d145164d424b5.htm 424B5 579628
2 GRAPHIC g145164d0001_818392.jpg GRAPHIC 49429
3 GRAPHIC g145164g02q20.jpg GRAPHIC 33289
4 GRAPHIC g145164g0301135729290.jpg GRAPHIC 977
5 GRAPHIC g145164new1.jpg GRAPHIC 61383
  Complete submission text file 0001193125-21-068370.txt   781076
Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Filer) CIK: 0001722926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-252575 | Film No.: 21712456
SIC: 2834 Pharmaceutical Preparations